Advertisement

Topics

For Vertex Pharmaceuticals, Can One Billion-Dollar Breakthrough Beget Another?

09:45 EDT 8 Aug 2017 | Forbes

Vertex Pharmaceuticals' new $200,000-a-year cystic fibrosis drug could help 90% of patients breathe. It's an amazing--and amazingly profitable--innovation. But will that windfall spur the 28-year-old startup to do it again?

Original Article: For Vertex Pharmaceuticals, Can One Billion-Dollar Breakthrough Beget Another?

NEXT ARTICLE

More From BioPortfolio on "For Vertex Pharmaceuticals, Can One Billion-Dollar Breakthrough Beget Another?"

Quick Search
Advertisement
 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...